Class Action Lawsuit Announcement: Bronstein Gewirtz Grossman LLC Invites Block, Inc. Investors Suffering Significant Losses to Take Action

Class Action Lawsuit Filed Against Block, Inc.: What Does This Mean for Investors and the World? On March 5, 2025, Bronstein, Gewirtz & Grossman, LLC, a prominent law firm, announced the filing of a class action lawsuit against Block, Inc. (NYSE: SQ), also known as Square, and certain of its officers. The lawsuit alleges that…

Read More

Advancements in MASH Therapy: A Closer Look at Altimmune’s Pemvidutide Shining Bright in the Wound Healing Space

Altimmune’s Exciting Advancements in NASH Treatment: IMPACT Study Results and Future Prospects Altimmune, Inc., a clinical-stage biopharmaceutical company, is making significant strides in the field of non-alcoholic steatohepatitis (NASH) treatment. The company’s top-line data from the phase 2b IMPACT study using pemvidutide is expected to be unveiled in the second quarter of 2025. This study…

Read More

SIGA to Hold Business Update Call on March 11, 2025: Insights from Q4 and Full Year 2024 Financial Results

SIGA Technologies: Business Update Webinar Announcement On March 4, 2025, SIGA Technologies, Inc., a Nasdaq-listed pharmaceutical company, made an important announcement regarding an upcoming business update webinar. This event is scheduled for 4:30 P.M. ET on Tuesday, March 11, 2025. Company Leadership to Present The webinar will feature presentations from Diem Nguyen, the Chief Executive…

Read More

Curve Finance (CRV) Contemplates Decreasing TUSD Exposure in Light of SEC Settlement

DEX Curve Finance Considers Reducing Dependence on TUSD Stablecoin Background DEX Curve Finance is currently evaluating a proposal to lessen its reliance on the TUSD stablecoin after the US Securities and Exchange Commission (SEC) dropped charges against the issuers Truecoin and Trusttoken. The SEC had accused the entities of violating securities policies by utilizing risky…

Read More